Assessment of in vivo oxidative stress in hypertensive rats and hypertensive subjects in Tanzania, Africa

Hypertension Research

Volumn 23, Issue 3, 2000, Pages 285-289

  Negishi, Hiroko ^a   Njelekela, Marina ^a   Ikeda, Katsumi ^a   Sagara, Miki ^a   Noguchi, Takanori ^a   Kuga, Sachiko ^a   Kanda, Tomo ^a   Liu, Longjian ^a   Nara, Yasuo ^b   Tagami, Motoki ^c   Yamori, Yukio ^a  

^a KYOTO UNIVERSITY   (Japan)

^b UNIVERSITY OF EAST ASIA   (Japan)

^c Sanraku Hospital   (Japan)

Author keywords

8 OHdG; African; Hypertension; Oxidative stress; SHRSP; Tanzania

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; BIOLOGICAL MARKER; CREATININE;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONFERENCE PAPER; CONTROLLED STUDY; DNA DAMAGE; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NONHUMAN; OXIDATIVE STRESS; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; TANZANIA; URINE LEVEL;

EID: 0034105116     PISSN: 09169636     EISSN: None     Source Type: Journal    
DOI: 10.1291/hypres.23.285     Document Type: Conference Paper

References (26)

1. Stephen T, Sinatra MD, Jan Demarco RN: Free radicals, oxidative low density lipoprotein (LDL), and the heart: antioxidants and other strategies to limit cardiovascular damage. Conn Med 1995; 59: 579-588.
2. Flora S, Izzotti A, Walsh D, Degan P, Petrilli G, Lewtas J: Molecular epidemiology of atherosclerosis. FASEB 1997; 11: 1021-1031.
3. Tagesson C, Kallberg M, Klintenberg C, Starkhammar H: Determination of urinary 8-hydroxydeoxyguanosine by automated coupled-column high performance liquid chromatography: a powerful technique for assaying in vivo oxidative DNA damage in cancer patients. Eur J Cancer 1995; 31A: 934-940.
4. Erhola M, Toyokuni S, Okada K, et al: Biomarker evidence of DNA oxidation in lung cancer patients: association of urinary 8-hydroxy-2′-deoxyguanosine excretion with radiotherapy, chemotherapy, and response to treatment. FEBS Lett 1997; 409: 287-291.
5. Lacy F, O'Connor D, Schmid-Schonbein G: Plasma hydrogen peroxide production in hypertensives and normotensive subjects at genetic risk of hypertension. J Hypertens 1998; 16: 291-303.
6. Russo C, Olivieri O, Girelli D, et al: Anti-oxidant status and lipid peroxidation in patients with essential hypertension. J Hypertens 1998; 16: 1267-1271.
7. McIntyre M, Hamilton C, Rees D, Reid J, Dominiczak A: Sex differences in the abundance of endothelial nitric oxide in a model of genetic hypertension. Hypertension 1997; 30: 1517-1524.
8. Tagami M, Yamagata K, Ikeda K, et al: Genetic vulner-ability of cortical neurons isolated from stroke-prone spontaneously hypertensive rats in hypoxia and oxygen reperfusion. Hypertens Res 1999; 22: 23-29.
9. Loft S, Vistisen K, Ewertz M, Tjonneland A, Overvad K, Poulsen E: Oxidative DNA damage estimated by 8-hydroxydeoxyguanosine excretion in humans: influence of smoking, gender and body mass index. Carcinogenesis 1992; 13: 2241-2247.
10. Zhang D, Okada S, Yu Y, Zheng P, Yamaguchi R, Kasai H: Vitamin E inhibits apoptosis. DNA modification, and cancer incidence induced by iron-mediated peroxidation in Wistar rat kidney. Cancer Res 1997; 57: 2410-2414.
11. Toyokuni S, Tanaka T, Hattori Y, et al: Quantitative immunohistochemical determination of 8-hydroxy-2′-deoxyguanosine by a monoclonal antibody N45.1: its application to ferric nitrilotriacetate-induced renal carcinogenesis model. Lab Inv 1997; 76: 365-374.
12. Witherell HL, Hiatt RA, Replogle M, Parsonnet J: Helicobacter pylori infection and urinary excretion of 8-hydroxy-2-deoxyguanosine, an oxidative DNA adduct. Cancer Epidemiol Biomarkers Prev 1998; 7: 91-96.
13. Shigenage M, Gimeno C, Ames B: Urinary 8-hydroxy-2′-deoxyguanosine as a biological marker of in vivo oxidative DNA damage. Proc Natl Acad Sci USA 1989; 86: 9697-9701.
14. Leinonen J, Lehtimaki T, Toyokuni S, et al: New biomarker evidence of oxidative DNA damage in patients with non-insulin-dependent diabetes mellitus. FEBS Lett 1997; 417: 150-152.
15. Fraga C, Shigenaga M, Park J, Degan P, Ames B: Oxidative damage to DNA during aging: 8-hydroxy-2′-deoxyguanosine in rat organ DNA and urine. Proc Natl Acad Sci USA 1990; 87: 4533-4537.
16. Pilger A, Germadnik D, Formanek D, Zwick H, Winkler N, Rudiger HW: Habitual long-distance running does not enhance urinary excretion of 8-hydroxydeoxyguanosine. Eur J Appl Physiol 1997; 75: 467-469.
17. Gao M, Ikeda K, Hattori H, Miura A, Nara Y, Yamori Y: Cardiovascular risk factors emerging in Chinese populations undegoing urbanization. Hypertens Res 1999; 22: 209-215.
18. Fukui T, Ishizaka N, Rajagopalan S, et al: p22phox mRNA expression and NADPH oxidase activity are increased in aortas from hypertensive rats. Circ Res 1997; 80: 45-51.
19. Munzel T, Heitzer T, Harrison D: The physiology and pathophysiology of the nitric oxide/superoxide system. Herz 1997; 22: 158-172.
20. Mizutani K, Ikeda K, Kawai Y, Yamori Y: Biochemical properties and chemical composition of the aorta in genetic hypertensive rats. J Hypertens 1999; 17: 481-487.
21. Nagai R, Ikeda K, Higashi T, et al: Hydroxyl radical mediates N epsilon-(carboxymethyl) lysine formation from Amadori product. Biochem Biophys Res Commun 1997; 234: 167-172.
22. Fu S, Fu MX, Baynes JW, Thorpe SR, Dean RT: Presence of dopa and amino acid hydroperoxides in proteins modified with advanced glycation end products (AGEs): amino acid oxidation products as a possible source of oxidative stress induced by AGE proteins. Biochem J 1998; 330: 233-239.
23. Sakata N, Miyamoto K, Meng J, et al: Oxidative damage of vascular smooth muscle cells by the glycated protein-cupric ion system. Atherosclerosis 1998; 136: 263-274.
24. Mtabaji JP, Nara Y, Moriguchi Y, Yamori Y: Diet and hypertension in Tanzania. Cardiovas Pharmacol 1990; 16 (Suppl 8): S3-S5.
25. Maro EE, Lwakatare J: Medication compliance among Tanzanian hypertensives. East Afr Med J 1997; 74: 539-542.
26. Cosentino F, Hishikawa K, Katusic ZS, Luscher TF: High glucose increased nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells. Circulation 1997; 96: 25-28.